SCHEMBL16085055

SCHEMBL16085055

CCN1CCC(COc2cc3ncnc(Nc4ccc(Br)cc4F)c3cc2OC)CC1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 16/20 0.84
KDR P35968 14/20 0.84
FGFR1 P11362 12/20 0.84
FLT1 P17948 12/20 0.84
FLT4 P35916 12/20 0.84
EPHA2 P29317 3/20 0.84
EPHB4 P54760 3/20 0.84
RET P07949 3/20 0.84
PDGFRB P09619 2/20 0.84
TEK Q02763 2/20 0.84
KIF5B P33176 2/20 0.84
BMPR1B O00238 1/20 0.84
PLK4 O00444 1/20 0.84
CIT O14578 1/20 0.84
GAK O14976 1/20 0.84
EPHB6 O15197 1/20 0.84
RIPK2 O43353 1/20 0.84
ROCK2 O75116 1/20 0.84
STK10 O94804 1/20 0.84
MAP4K4 O95819 1/20 0.84

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1657315 0.92 EGFR (0.83) EGFRKDRFGFR1FLT1FLT4
Vandetanib SCHEMBL9044 0.91 EGFR (1.00) EGFRKDRFGFR1FLT1FLT4
Vandetanib SCHEMBL28224661 0.91 EGFR (1.00) EGFRKDRFGFR1FLT1FLT4
Vandetanib SCHEMBL29352879 0.91 EGFR (1.00) EGFRKDRFGFR1FLT1FLT4
SCHEMBL20343335 0.91 EGFR (0.80) EGFRKDRFGFR1FLT1FLT4
SCHEMBL26359052 0.91 EGFR (0.85) EGFRKDRFGFR1FLT1FLT4
Vandetanib SCHEMBL4637084 0.91 EGFR (0.98) EGFRKDRFGFR1FLT1FLT4
Vandetanib SCHEMBL1614458 0.91 EGFR (1.00) EGFRKDRFGFR1FLT1FLT4
SCHEMBL23965916 0.88 EGFR (0.80) EGFRKDRFGFR1FLT1FLT4
SCHEMBL18627731 0.88 EGFR (0.80) EGFRKDRFGFR1FLT1FLT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014141057-A2 COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER KANDULA MAHESH (IN) 2014-09-18 WO disclosed